Phase 2 Tuberculosis Trial, Recruiting NCT06446245 Sponsor: National University Hospital, Singapore Condition: Tuberculosis
Back to Tuberculosis

Phase 2 Tuberculosis Trial, Recruiting

NCT06446245
Recruiting Phase 2

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are 21 years of age or older.
  • You have either just started TB treatment (within the last 7 days or less) or are about to begin TB treatment.
  • You have been diagnosed with, or are strongly suspected to have, tuberculosis (TB) affecting the brain and/or its surrounding lining (TB meningitis) — this includes cases that are confirmed by lab tests, or considered likely or possible based on symptoms and test results.
  • Your liver enzyme levels (a measure of liver health from a blood test) are within an acceptable range — not more than 3 times the upper limit of normal.
  • You are able to give your own consent to take part, or a close family member is able to give consent on your behalf if you are unable to do so yourself.
  • You are able to have a lumbar puncture (a procedure to collect fluid from around the spine) and a brain scan (either a CT or MRI scan) at the start of the study.

Who may not be able to join:

  • You currently have active cancer.
  • You are pregnant or breastfeeding.
  • You have a known allergy to a group of antibiotics called tetracyclines.
  • You are currently taking certain medications — specifically retinoic acid, neuromuscular blocking agents, or pimozide — which could increase the risk of harmful drug interactions.
  • You have an autoimmune disease or are currently taking medicines that suppress your immune system.
  • You have taken part in another clinical trial or used an experimental drug, vaccine, or medical device in the past 6 months (182 days), or plan to do so during this study.
  • You are currently enrolled in another clinical trial that involves a medication or procedure affecting the brain or nervous system.
  • You have a medical reason why you cannot safely take steroids.
  • The trial doctors believe you may be unwilling or unable to follow the study's requirements, including attending follow-up visits, or they have identified something that could put you at significantly higher risk of harm by taking part (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
Phase 2: approximately ~30% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.
Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 2
Sponsor
National University Hospital, Singapore
Registry
ClinicalTrials.gov
Start date
21 August 2025
Est. completion
1 November 2027

Where this trial is recruiting

🇮🇩 Indonesia 🇲🇾 Malaysia 🇸🇬 Singapore

Primary endpoints

Mortality or severe neurological deficits (modified Rankin scale of 3 or more) at 8 weeks, from time of randomization.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov